Omeros Corporation (OMER)

$5.14

-0.14

(-2.65%)

Live

Performance

  • $5.09
    $5.40
    $5.14
    downward going graph

    0.92%

    Downside

    Day's Volatility :5.69%

    Upside

    4.81%

    downward going graph
  • $0.92
    $5.68
    $5.14
    downward going graph

    82.1%

    Downside

    52 Weeks Volatility :83.8%

    Upside

    9.51%

    downward going graph

Returns

PeriodOmeros CorporationSector (Health Care)Index (Russel 2000)
3 Months
67.62%
6.5%
0.0%
6 Months
60.49%
7.1%
0.0%
1 Year
19.73%
9.8%
0.0%
3 Years
-63.28%
14.2%
-20.2%

Highlights

Market Capitalization
316.4M
Book Value
- $1.23
Earnings Per Share (EPS)
-2.81
PEG Ratio
-0.17
Wall Street Target Price
43.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-21.03%
Return On Equity TTM
-576.33%
Revenue TTM
-30.0M
Revenue Per Share TTM
-0.48
Quarterly Revenue Growth YOY
14.899999999999999%
Gross Profit TTM
-71.4M
EBITDA
-166.9M
Diluted Eps TTM
-2.81
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-2.41
EPS Estimate Next Year
-1.98
EPS Estimate Current Quarter
-0.58
EPS Estimate Next Quarter
-0.56

Analyst Recommendation

Buy
    66%Buy
    33%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for Omeros Corporation(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
3
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 736.58%

Current $5.14
Target $43.00

Technicals Summary

Sell

Neutral

Buy

Omeros Corporation is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Omeros Corporation
Omeros Corporation
38.22%
60.49%
19.73%
-63.28%
-65.74%
Moderna, Inc.
Moderna, Inc.
-1.67%
18.26%
-0.21%
-64.15%
752.69%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.46%
13.21%
45.59%
84.19%
244.2%
Novo Nordisk A/s
Novo Nordisk A/s
-11.0%
18.31%
61.56%
186.46%
423.59%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.85%
14.43%
39.88%
147.45%
195.07%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Omeros Corporation
Omeros Corporation
1.43
NA
-0.17
-2.41
-5.76
-0.21
NA
-1.23
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.19
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.35
31.35
1.46
44.44
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
44.28
44.28
2.36
3.43
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.85
31.85
0.53
16.98
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Omeros Corporation
Omeros Corporation
Buy
$316.4M
-65.74%
1.43
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$45.3B
752.69%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$116.9B
244.2%
31.35
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$572.0B
423.59%
44.28
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.7B
195.07%
31.85
39.46%

Insights on Omeros Corporation

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 61.6% return, outperforming this stock by 41.9%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 186.5% return, outperforming this stock by 249.8%

Institutional Holdings

  • Ingalls & Snyder LLC

    8.11%
  • BlackRock Inc

    7.27%
  • Vanguard Group Inc

    5.61%
  • Stifel Financial Corp

    3.29%
  • D. E. Shaw & Co LP

    2.90%
  • Geode Capital Management, LLC

    2.38%

Company Information

omeros is a seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.

Organization
Omeros Corporation
Employees
198
CEO
Dr. Gregory A. Demopulos M.D.
Industry
Health Technology

FAQs